Biosimilar of Remicade Works in Ankylosing Spondylitis (CME/CE)
(MedPage Today) -- No differences in immunogenicity were observed, authors say (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - January 27, 2016 Category: Geriatrics Source Type: news
Gut bacteria could lead to new treatment for inflammatory arthritis
Studying the trillions of bacteria and other microbes that share our body space could lead to a preventative treatment for immune diseases such as rheumatoid arthritis.
It's long been suggested that the bacteria which live in our gut, mouth and elsewhere on our bodies may affect our immune system and lead to the development of certain diseases, including rheumatoid arthritis. But exactly how changes to these bacteria, collectively called the “microbiome”, cause disease remains to be discovered.
The research, which we awarded £2 million to, aims to unlock the link between gut bacteria and the development o...
Source: Arthritis Research UK - January 21, 2016 Category: Rheumatology Source Type: news
Secukinumab receives FDA approval for psoriatic arthritis, ankylosing spondylitis
The Food and Drug Administration approved two new indications for the interleukin-17A inhibitor secukinumab (Cosentyx) – psoriatic arthritis in adults and ankylosing spondylitis in adults – on Jan. 15. These join the approval for moderate to severe plaque psoriasis in adults it received in January... (Source: Skin and Allergy News)
Source: Skin and Allergy News - January 18, 2016 Category: Dermatology Source Type: news
US FDA approves Cosentyx for ankylosing spondylitis and psoriatic arthritis treatment
Swiss drug maker Novartis has secured approvals from the US Food and Drug Administration (FDA) for injectable medication Cosentyx for two new indications, which can now be used to treat patients having ankylosing spondylitis (AS) and psoriatic arthri… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - January 18, 2016 Category: Pharmaceuticals Source Type: news
Novartis receives two new FDA approvals for Cosentyx(R) (secukinumab) to treat patients with ankylosing spondylitis and psoriatic arthritis
Cosentyx is the first and only interleukin-17A (IL-17A) antagonist approved for adult patients with active ankylosing spondylitis (AS) and psoriatic arthritis (PsA)
Approvals for both indications based on efficacy and safety outcomes shown across four P... Biopharmaceuticals, FDANovartis, Cosentyx, secukinumab, psoriasis, ankylosing spondylitis, arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 16, 2016 Category: Pharmaceuticals Source Type: news
Novartis Receives FDA Approval for Cosentyx (secukinumab) to Treat Patients with Ankylosing Spondylitis and Psoriatic Arthritis
EAST HANOVER, N.J., Jan. 15, 2016 Novartis announced today that the US Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) for two new indications - the treatment of adult patients with active ankylosing spondylitis (AS) and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 15, 2016 Category: Drugs & Pharmacology Source Type: news
Poor Bone Structure Common in AS Patients (CME/CE)
(MedPage Today) -- Abnormalities may help explain fractures in ankylosing spondylitis (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - January 7, 2016 Category: Rheumatology Source Type: news
Pregnancy Problems Common With Spine Disease (CME/CE)
(MedPage Today) -- C-section, preeclampsia, preterm birth frequent in women with ankylosing spondylitis (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - December 29, 2015 Category: Primary Care Source Type: news
Study: Not All axSpA Progresses to Ankylosing Spondylitis (CME/CE)
(MedPage Today) -- Axial spondyloarthritis may be a prolonged prodromal state, authors say (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - December 27, 2015 Category: Rheumatology Source Type: news
New Drug for Severe Form of Arthritis Shows Promise in Trial
Already approved to treat psoriasis, higher dose of Cosentyx helped 60 percent of patients
Source: HealthDay
Related MedlinePlus Pages: Ankylosing Spondylitis, Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 25, 2015 Category: Consumer Health News Source Type: news
Secukinumab cut ankylosing spondylitis symptoms in MEASURE trials
Secukinumab, an interleukin 17-A inhibitor approved for the treatment of moderate to severe psoriasis, significantly reduced the signs and symptoms of ankylosing spondylitis in two phase III trials, researchers reported Dec. 23 in the New England Journal of Medicine.
The results of the... (Source: Skin and Allergy News)
Source: Skin and Allergy News - December 23, 2015 Category: Dermatology Source Type: news
On-Demand Doses of Infliximab in Ankylosing SpondylitisOn-Demand Doses of Infliximab in Ankylosing Spondylitis
Would ankylosing spondylitis patients benefit from a treatment regimen of on-demand maintenance dosing with infliximab? Journal of Clinical Rheumatology (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - December 2, 2015 Category: Orthopaedics Tags: Rheumatology Journal Article Source Type: news
DR ELLIE CANNON: I'm losing sleep over back ache
The Mail on Sunday's GP answers readers' questions on ankylosing spondylitis and chronic kidney disease, and praises Oprah Winfrey for her decision to use WeightWatchers. (Source: the Mail online | Health)
Source: the Mail online | Health - October 26, 2015 Category: Consumer Health News Source Type: news
Genders Differ in Perception of Ankylosing Spondylitis (CME/CE)
(MedPage Today) -- Men had a better quality of life, but more objective damage (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - September 30, 2015 Category: Primary Care Source Type: news
An Important Consideration in Ankylosing Spondylitis An Important Consideration in Ankylosing Spondylitis
Dr Jonathan Kay talks about indication and treatment discrepancies on the ankylosing spondylitis spectrum, saying that some back pain patients end up excluded from some effective treatments. Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - September 25, 2015 Category: Rheumatology Tags: Rheumatology Commentary Source Type: news
